FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity
The machine has hardware upgrades, software enhancements, and an exterior with hospital grade durability. Outset anticipates that customers will start receiving these machines in the second half of 2026.
Read the full article » | Posted 02-17-2026
Related Articles
- Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
- AWAK PD To Go Posted 10-05-2026
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026